Published in
Elsevier, Lung Cancer, (155), p. 151-155, 2021
DOI: 10.1016/j.lungcan.2021.02.034
Links
Tools
Tolerability and antitumor activity of cemiplimab, a human monoclonal anti–PD-1, as monotherapy in patients with pretreated non-small cell lung cancer (NSCLC): Data from the Phase 1 NSCLC expansion cohort
Journal article published in 2021 by
Victor Moreno 
,
Pilar Garrido ,
Kyriakos P. Papadopoulos ,
Maria Jose De Miguel Luken ,
Marta Gil-Martin ,
Raid Aljumaily,
Lee S. Rosen,
Petra Rietschel,
Kosalai K. Mohan,
Suk-Young Yoo,
Elizabeth Stankevich ,
Israel Lowy ,
Matthew G. Fury
,
Pilar Garrido ,
Kyriakos P. Papadopoulos ,
Maria Jose De Miguel Luken ,
Marta Gil-Martin ,
Raid Aljumaily,
Lee S. Rosen,
Petra Rietschel,
Kosalai K. Mohan,
Suk-Young Yoo,
Elizabeth Stankevich ,
Israel Lowy ,
Matthew G. Fury
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 